Nuñez-Aguilar J, Fernández-Olavarría A, Oliveros-López LG, Torres-La­gares D, Serrera-Figallo MA, Gutiérrez-Corrales A, Gutiérrez-Pérez JL. Evolution of oral health in oral cancer patients with and without dental treatment in place: Before, during and after cancer treatment. J Clin Exp Dent. 2018;10(2):e158-65.

 

doi:10.4317/jced.54608

http://dx.doi.org/doi:10.4317/jced.54608

 

References

1. Fernández-Olavarría A, Mosquera-Pérez R, Díaz-Sánchez RM, Serrera-Figallo MA, Gutiérrez-Pérez JL, Torres-Lagares D. The role of serum biomarkers in the diagnosis and prognosis of oral cancer: A systematic review. J Clin Exp Dent. 2016;8:e184-193.
https://doi.org/10.4317/jced.52736

PMid:27034760 PMCid:PMC4808315

 

2. FDI policy statement on oral cancer: Adopted by the FDI General Assembly: 24 September 2015, Bangkok, Thailand. FDI World Dental Federation. Int Dent J. 2016;66:13-14.
https://doi.org/10.1111/idj.12234
PMid:26803944

 

3. Balaram P, Sridhar H, Rajkumar T, Vaccarella S, Herrero R, Nandakumar A, et al. Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer. 2002; 98:440-445.
https://doi.org/10.1002/ijc.10200
PMid:11920597

 

4. Zygogianni AG, Kyrgias G, Karakitsos P, Psyrri A, Kouvaris J, Kelekis N, et al. Oral squamous cell cáncer: early detection and the role of alcohol and smoking. Head Neck Oncol. 2011 6;3:2.

PMid:21211041 PMCid:PMC3022893

 

5. Torres-Carranza E, Infante-Cossío P, Hernández-Guisado JM, Hens-Aumente E, Gutierrez-Pérez JL. Assessment of quality of life in oral cancer. Med Oral Patol Oral Cir Bucal. 2008;13:E735–741.
PMid:18978717

 

6. Pelucchi C, Gallus S, GaravelloW, Bosetti C, La Vecchia C. Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev. 2008;17:340–344.
https://doi.org/10.1097/CEJ.0b013e3282f75e91
PMid:18562959

 

7. Martín-Hernán F, Sánchez-Hernández JG, Cano J, Campo J, del Romero J. Oral cáncer, HPPV infection and evidence of sexual transmission. Med Oral Patol Oral Cir Bucal. 2013;18:e439-444.
https://doi.org/10.4317/medoral.18419
PMid:23524417 PMCid:PMC3668870

 

8. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695-1709.
https://doi.org/10.1016/S0140-6736(08)60728-X

PMid:18486742

 

9. Andrews E, Seaman WT,Webster-Cyriaque J. Oropharyngeal carcinoma in non-smokers and non-drinkers: a role for HPV. Oral Oncol. 2009;45:486–491.
https://doi.org/10.1016/j.oraloncology.2008.07.008
PMid:19027350

 

10. Ringstrom E, Peters E, HasegawaM, PosnerM, LiuM, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer. 2002;8:3187-3192.

PMid:12374687

 

11. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-1956.
https://doi.org/10.1056/NEJMoa065497
PMid:17494927

 

12. Ahrens W, Pohlabeln H, Foraita R. Oral health, dental care and mouthwash associated with upper aerodigestive tract cáncer risk in Europe: the ARCAGE study. Oral Oncol. 2014;50:616-625.
https://doi.org/10.1016/j.oraloncology.2014.03.001
PMid:24680035

 

13. Escoda-Francolí J, Rodríguez-Rodríguez A, Pérez-García S, Gargallo-Albiol J, Gay-Escoda C. Dental implications in oral cáncer patients. Med Oral Patol Oral Cir Bucal. 2011;16:e508-513.
https://doi.org/10.4317/medoral.16.e508
PMid:20711136

 

14. Sonis ST, Woods PD, White BA. Oral complications of cancer therapies. Pretreatment oral assessment. NCI Monogr. 1990;9:29-32.

PMid:2342592

 

15. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998;34:39-43.
https://doi.org/10.1016/S1368-8375(97)00053-5

PMid:9659518

 

16. Epstein JB, Chow AW. Oral complications associated with inmunosuppression and cancer therapies. Infect Dis Clin North Am. 1999;13:901-23.
https://doi.org/10.1016/S0891-5520(05)70115-X

PMid:10579115

 

17. Toljanic JA, Bedard JF, Larson RA, Fox JP. A prospective pilot study to evaluate a new dental assessment and treatment paradigm for patients scheduled to undergo intensive chemotherapy for cancer. Cancer. 1999;85:1843-1848.
https://doi.org/10.1002/(SICI)1097-0142(19990415)85:8<1843::AID-CNCR26>3.0.CO;2-R

PMid:10223580

 

18. Infante-Cossio P, Torres-Carranza E, Cayuela A, Hens-Aumente E, Pastor-Gaitan P, Gutierrez-Perez JL. Impact of treatment on quality of life for oral and oropharyngeal carcinoma. Int J Oral Maxillofac Surg. 2009;38:1052–1058.
https://doi.org/10.1016/j.ijom.2009.06.008
PMid:19596557

 

19. Barrios R, Tsakos G, Gil-Montoya JA, Montero J, Bravo M. Association between general and oral health-related quality of life in patientes treated for oral cancer. Med Oral Patol Oral Cir Bucal. 2015;20:e678-684.
https://doi.org/10.4317/medoral.20714
PMid:26449436 PMCid:PMC4670247

 

20. Bueno AC, Ferreira RC, Barbosa FI, Jham BC, Magalhaes CS, Moreira AN. Periodontal care in patients undergoing radiotherapy for head and neck cancer. Support Care Cancer. 2013; 21:969–975.
https://doi.org/10.1007/s00520-012-1614-5
PMid:23052920

 

21. Critchlow SB, Morgan C, Leung T. The oral health status of pre-treatment head and neck cancer patients. Br Dent J. 2014;216:E1.
https://doi.org/10.1038/sj.bdj.2013.1246
PMid:24413141

 

22. Jham BC, Reis PM, Miranda EL, Lopes RC, Calvalho AL, Scheper MA, Freire AR. Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin Oral Investig. 2008;12:19–24.
https://doi.org/10.1007/s00784-007-0149-5
PMid:17876612

 

23. Lockhart PB, Clark J. Pretherapy dental status of patients with malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol. 1994;77:236–241.
https://doi.org/10.1016/0030-4220(94)90291-7

PMid:8170653

 

24. Schuurhuis JM, Stokman MA, Roodenburg JL, Reintsema H, Langendijk JA, Vissink A, et al. Efficacy of routine pre-radiation dental screening and dental follow-up in head and neck oncology patients on intermediate and late radiation effects. A retrospective evaluation. Radiother Oncol. 2011;101:403–409.
https://doi.org/10.1016/j.radonc.2011.09.018
PMid:22001103

 

25. Galler C, Epstein JB, Guze KA, Buckles D, Stevenson-Moore P. The development of osteoradionecrosis from sites of periodontal disease activity: report of 3 cases. J Periodontol. 1992;63:310–316.
https://doi.org/10.1902/jop.1992.63.4.310
PMid:1573545

 

26. Montero J, Yarte JM, Bravo M, López-Valverde A. Oral health-related quality of life of a consecutive sample of Spanish dental patients. Med Oral Patol Oral Cir Bucal. 2011;16:810–815.
https://doi.org/10.4317/medoral.16790

 

27. Silverman S Jr. Oral cancer: complications of therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88:122-126.
https://doi.org/10.1016/S1079-2104(99)70103-4

 

28. Katsura K, Sasai K, Sato K, Saito M, Hoshina H, Hayashi T.Relationship between oral health status and development of osteoradionecrosis of the mandible: a retrospective longitudinal study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:731-738.
https://doi.org/10.1016/j.tripleo.2007.10.011
PMid:18329913

 

29. Koga DH, Salvajoli JV, Kowalski LP, Nishimoto IN, Alves FA. Dental extractions related to head and neck radiotheraphy: ten year experience of a single institution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:e1-6.
https://doi.org/10.1016/j.tripleo.2008.01.007
PMid:18329909

 

30. Saito H, Watanabe Y, Sato K, Ikawa H, Yoshida Y, Katakura A, Takayama S, Sato M. Effects of profesional oral health care on reducing the risk of chemotherapy-induced oral mucositis. Support Care Cancer. 2014;22:2935-2940.
https://doi.org/10.1007/s00520-014-2282-4
PMid:24854326 PMCid:PMC4183888

 

31. Kielbassa AM, Hinkelbein W, Hellwing E, Meyer-Luckel H. Post-radiation´s dentition lesions. Lancet Oncol. 2006;7:326-335.
https://doi.org/10.1016/S1470-2045(06)70658-1

 

32. Bertl K, Loidl S, Kotowski U, Heiduschka G, Thurnher D, Stavropoulos A, Schneinder-Stickler B. Oral health status and dental care behaviours of head and neck cancer patients: a cross-sectional study in an Austrian tertiary hospital. Clin Oral Investig. 2016;20:1317-1327.
https://doi.org/10.1007/s00784-015-1618-x
PMid:26452977

 

33. Huang SH, O'Sullivan B. Oral cancer: Current role of radiotheraphy and chemotheraphy. Med Oral Patol Oral Cir Bucal. 2013;18:e233-240.
https://doi.org/10.4317/medoral.18772
PMid:23385513 PMCid:PMC3613874

 

34. Niewald M, Mang K, Barbie O, Fleckenstein J, Holtmann H, Spitzer WJ, Rübe C. Dental status, dental treatment procedures and radiotheraphy as risk factors for infected osteoradionecrosis (IORN) in patients with oral cancer – a comparision of two 10 years' observation periods. Springerplus. 2014;3:263.
https://doi.org/10.1186/2193-1801-3-263
PMid:24936388 PMCid:PMC4048661

 

35. Niewald M, Fleckenstein J, Mang K, Holtmann H, Spitzer WJ, Rübe C. Dental status, dental rehabilitation procedures, demographic and oncological data as potential risk factors for infected osteradionecrosis of the lower jaw after radiotherapy for oral neoplasm: a retrospective evaluation. Radiat Oncol. 2013;8:227.
https://doi.org/10.1186/1748-717X-8-227
PMid:24088270 PMCid:PMC3851528

 

36. Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884-11894.
PMid:26617944 PMCid:PMC4637760

 

37. Devi S, Singh N. Dental care during and after radiotherapy in head and neck cancer. Natl J Maxillofac Surg. 2014;5:117-125.
https://doi.org/10.4103/0975-5950.154812
PMid:25937720 PMCid:PMC4405951

 

38. van der Waal I, de Bree R, Brakenhoff R, Coebergh JW. Early diagnosis in primary oral cáncer: is it possible? Med Oral Patol Oral Cir Bucal. 2011;16:e300-305.
https://doi.org/10.4317/medoral.16.e300
PMid:21441877

 

39. Mehanna H, Paleri V, West CM, Nutting C. Head and neck cancer-part 1: epidemiology, presentation, and prevention. BMJ. 2010;341:c4684.
https://doi.org/10.1136/bmj.c4684
PMid:20855405